Additional file 1 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

  • Simone Borgoni (Contributor)
  • Stefan Wiemann (Contributor)
  • Maryam Soleimani Dodaran (Contributor)
  • Pernette J. Verschure (Contributor)
  • Emre Sofyall (Contributor)
  • Antoine H C van Kampen (Contributor)
  • Perry D Moerland (Contributor)

Dataset

Description

Additional file 1. Mapping to generic drug names. Overview of synonyms and spelling variants for drug names used in TCGA BRCA and their mapping to a generic drug name used in our study.
Date made available1 Jan 2020
Publisherfigshare Academic Research System

Cite this